Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV

NCT00246402 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Insulin Resistance
Cardiovascular Diseases
Heart Diseases
HIV Infections
Hypertriglyceridemia
Hyperlipidemia

Interventions

DRUG: Acipimox

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)